Edwards Lifesciences (EW) revenue: $6.1B
Edwards Lifesciences reported $6.1B of revenue for the year ended Dec 31, 2025, up 11.5% from $5.4B a year earlier.
From Edwards Lifesciences's filings with the SEC · Read the filing · EW stock page
Edwards Lifesciences revenue by year
#612 of 3,623 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $6.1B | +12% |
| Dec 31, 2024 | $5.4B | +9% |
| Dec 31, 2023 | $5B | +12% |
| Dec 31, 2022 | $4.5B | -15% |
| Dec 31, 2021 | $5.2B | – |
Revenue of similar companies
Companies in the same industry as Edwards Lifesciences, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Intuitive Surgical | $10.1B | Dec 31, 2025 |
| Zimmer Biomet Holdings | $8.2B | Dec 31, 2025 |
| Edwards Lifesciences | $6.1B | Dec 31, 2025 |
| STERIS | $5.9B | Mar 31, 2026 |
| Align Technology | $4B | Dec 31, 2025 |
| Enovis | $2.2B | Dec 31, 2025 |
| MSA Safety | $1.9B | Dec 31, 2025 |
Questions and answers
What is Edwards Lifesciences's revenue?
Edwards Lifesciences reported $6.1B of revenue for the year ended Dec 31, 2025, up 11.5% from $5.4B a year earlier.
Numbers as reported in Edwards Lifesciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology